Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brivudine (BVDU), an antiviral medicine, is used in the therapy of herpes zoster.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 39.00 | |
50 mg | In stock | $ 55.00 | |
100 mg | In stock | $ 72.00 | |
200 mg | In stock | $ 98.00 | |
500 mg | In stock | $ 158.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Brivudine (BVDU), an antiviral medicine, is used in the therapy of herpes zoster. |
In vitro | Brivudine is an analog of thymidine, and is incorporated into the viral DNA. It blocks the action of DNA polymerases thereby inhibiting viral replication. It has a stronger antiviral effect against the varicella-zoster virus than reference compounds such as aciclovir or penciclovir[1]. It has high, selective activity against varicella zoster virus (VZV), inhibiting VZV replication, possibly through competitive inhibition of viral DNA polymerase, or by acting as an alternative substrate to deoxythymidine triphosphate, causing viral DNA strand breakage[2]. |
In vivo | At a dose of 125 mg once daily, brivudine has been shown to be superior to aciclovir with respect to reducing the period of new blister production and shortening the duration of post-herpetic neuralgia[1]. |
Synonyms | Bromovinyldeoxyuridine, BVDU |
Molecular Weight | 333.14 |
Formula | C11H13BrN2O5 |
CAS No. | 69304-47-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 330 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brivudine 69304-47-8 Microbiology/Virology Others HSV Cytomegalovirus CMV Inhibitor Bromovinyldeoxyuridine BVDU inhibit inhibitor